Abstract
Cholangiocarcinoma (CCA) is a primary hepatic neoplasm that arises from malignant transformation of the biliary epithelium. Chronic biliary tree inflammation as occurs in primary sclerosing cholangitis (PSC) is a risk factor for the development of CCA. Surgical resection and liver transplantation following neoadjuvant therapy in patients with early extrahepatic CCA are the only potentially curative modalities. Biliary stenting, chemotherapy, radiation therapy, and photodynamic therapy are palliative treatment options for patients who are not surgical candidates. Liver transplantation following neoadjuvant therapy is an effective therapy for patients with hilar cholangiocarcinoma that is unresectable or arising in the setting of PSC.
Original language | English (US) |
---|---|
Pages (from-to) | 699-715 |
Number of pages | 17 |
Journal | Clinics in liver disease |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2011 |
Keywords
- Acute cholangitis
- Biliary stenting
- Biliary stricture
- Cholangiocarcinoma
- Klatskin tumor
- Liver transplantation
- Living donor liver transplantation
- Neoadjuvant therapy
ASJC Scopus subject areas
- Hepatology